Showing results (621-630 of 834) with videos related to
Sort By:
Pageof 84
Journal of Neuro-Oncology|November 9, 2018
Mild cognitive impairment in long-term brain tumor survivors following brain irradiationChristina K Cramer, Neil McKee, L Doug Case, et al.Journal of Geriatric Psychiatry and Neurology|March 17, 2004
Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI)Sue J Kang, Seong H Choi, Byung Hwa Lee, et al.Neuropsychology|July 24, 2013
Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderlyDavid P Salmon, Steven H Ferris, Ronald G Thomas, et al.Neuroimage|June 1, 1994
Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalographyA F Leuchter, I A Cook, R B Lufkin, et al.Alzheimer'S Research & Therapy|December 21, 2022
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyEric McDade, Jeffrey L Cummings, Shobha Dhadda, et al.Neurology|May 9, 2001
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of NeurologyD S Knopman, S T DeKosky, J L Cummings, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|September 23, 2000
Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's diseaseM S Mega, I D Dinov, L Lee, et al.Experimental Brain Research|April 21, 2023
Cortical thickness is related to cognitive-motor automaticity and attention allocation in individuals with Alzheimer's disease: a regions of interest studyJason K Longhurst, Karthik R Sreenivasan, Jemma Kim, et al.Archives of Neurology|October 10, 2007
Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer diseaseLiana G Apostolova, Calen A Steiner, Gohar G Akopyan, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's diseaseJuha O Rinne, Keith Wesnes, Jeffrey L Cummings, et al.Pageof 84